Clinical Trials Browser

Prostatic Neoplasms × Acetates × Genitourinary × Clear all

NCT03999515 2023-09-28

Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer

Phase 2 Terminated

3 enrolled 9 charts

Prostatic Neoplasms